The relative expression level of all four members of the HER family (wt-EGFR, HER2, HER3, and HER4), as well as the mutant type of EGFR (EGFRvIII) proteins, were examined in the tumour specimens from these patients by immunohistochemistry. This evidence concerns the gene ERBB2 and neoplasm.